From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
EMD Serono
EMD Serono, based in Rockland, Mass., is an affiliate of Merck KGaA of Darmstadt, Germany. The company and affiliates agreed to pay $44.3 million in May 2011 to resolve allegations of improper marketing of the MS drug Rebif.
EMD Serono reports payments made to physicians beginning in January 2011. Its database includes payments for consulting, speaking, internal training, market research, publications, meals, travel and educational items.
The company removed payment information from its website in September 2014, after its Corporate Integrity Agreement with the U.S. Department of Health and Human Services inspector general expired the same month. Dollars for Docs includes payments through the end of 2013.
EMD Serono's 2013 U.S. sales: $1.7 billion. Source: IMS Health.
Notable drugs
Payment Reports
2011 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Meals | $204,507 | $818,027 |
Consulting | $140,794 | $563,176 |
Speaking | $82,441 | $329,763 |
Travel | $26,784 | $107,136 |
Items, Gifts | $6,762 | $27,046 |
Other | $963 | $3,850 |
Adjustment | -$9 | -$37 |
$462,240 | $1,848,961 |
2012 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Speaking | $248,084 | $992,335 |
Consulting | $168,430 | $673,721 |
Meals | $134,786 | $539,142 |
Travel | $79,902 | $319,606 |
Items, Gifts | $2,690 | $10,758 |
Other | $1,120 | $4,480 |
Adjustment | -$2 | -$9 |
$635,008 | $2,540,033 |
2013 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Speaking | $413,524 | $1,654,095 |
Consulting | $256,784 | $1,027,135 |
Meals | $144,803 | $579,211 |
Travel | $88,075 | $352,299 |
Other | $12,061 | $48,242 |
Items, Gifts | $197 | $789 |
$915,443 | $3,661,771 |
Total Payments by State
State | Total |
---|---|
California | $843,558 |
New York | $803,622 |
Massachusetts | $488,084 |
Illinois | $485,515 |
Maryland | $444,345 |
Pennsylvania | $406,039 |
Texas | $401,387 |
Florida | $370,625 |
Connecticut | $351,397 |
Michigan | $253,182 |
North Carolina | $251,225 |
New Jersey | $250,571 |
Ohio | $246,621 |
Georgia | $237,404 |
Washington | $200,145 |
Arizona | $189,604 |
Tennessee | $159,571 |
Colorado | $140,578 |
Virginia | $126,484 |
Oklahoma | $118,673 |
Indiana | $114,725 |
Missouri | $114,540 |
Oregon | $90,569 |
Nevada | $78,385 |
South Carolina | $75,878 |
New Hampshire | $71,437 |
Wisconsin | $70,885 |
Kentucky | $64,611 |
Alabama | $58,733 |
Arkansas | $55,426 |
District of Columbia | $55,120 |
Louisiana | $53,296 |
Minnesota | $43,854 |
Utah | $43,772 |
Iowa | $41,202 |
Maine | $34,890 |
Hawaii | $29,765 |
Mississippi | $26,253 |
Delaware | $24,649 |
New Mexico | $23,931 |
Idaho | $23,176 |
Kansas | $20,082 |
West Virginia | $15,357 |
Rhode Island | $12,672 |
Nebraska | $11,361 |
[Unknown State] | $8,818 |
North Dakota | $5,299 |
Alaska | $4,161 |
South Dakota | $4,010 |
Montana | $3,368 |
Vermont | $795 |
Wyoming | $757 |
Puerto Rico | $358 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.